Keloid Treatment Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Keloid Treatment Market
Keloid Treatment Market: By Product (Elastic Wraps, Sprays, Ointment, Creams, Oils, & Topical Gels & Gel Sheets), By Treatment (Radiation, Cry, Surgical, Laser, Steroid Injections, & Interferon), & By Region - Forecast(2018 - 2023)
Report Code : HCR 0234
Updated Date: 16 May, 2018  

1. Keloid Treatment Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Keloid Treatment Market– Market Forces
   4.1. Drivers
      4.1.1. Development of advance technology based treatment
      4.1.2. Rise in the appearance consciousness
      4.1.3. Increasing awareness about scare treatment products, and expenditure on personal care, and changing lifestyle
   4.2. Restraints
      4.2.1. Higher cost of treatment
      4.2.2. Risk of side effects and complications during treatment
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Increase in adoption of radiation therapy, surgical intervention, and steroid injections  for keloid treatment
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Keloid Treatment Market, By Product
   5.1. Elastic Wraps
   5.2. Sprays
   5.3. Ointment
   5.4. Creams
   5.5. Oils
   5.6. Topical Gels & Gel Sheets
6. Keloid Treatment Market, By Treatment
   6.1. Radiation Therapy
   6.2. Cry Therapy
   6.3. Surgical Treatment
   6.4. Laser Treatment
   6.5. Steroid Injections
   6.6. Interferon
7. Keloid Treatment Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Keloid Treatment – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. Bristol-Myers Squibb Company
   9.2. Valeant Pharmaceuticals International Inc.
   9.3. Renovo Group Plc
   9.4. Galena Biopharma, Inc.
   9.5. Pacific World Corporation
   9.6. RXi Pharmaceuticals, Inc.
   9.7. Novartis AG
   9.8. GlaxoSmithKline plc
   9.9. Revitol Corporation Inc.
   9.10. Avita Medical Limited
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll